Literature DB >> 24434172

A community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013.

E Takashita1, M Ejima, R Itoh, M Miura, A Ohnishi, H Nishimura, T Odagiri, M Tashiro.   

Abstract

Six influenza A(H1N1)pdm09 viruses were detected in Sapporo, Japan, between November and December 2013. All six viruses possessed an H275Y substitution in the neuraminidase protein, which confers cross-resistance to oseltamivir and peramivir. No epidemiological link among the six cases could be identified; none of them had received neuraminidase inhibitors before specimen collection. The haemagglutinin and neuraminidase genes of the six viruses were closely related to one another, suggesting clonal spread of a single resistant virus.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24434172     DOI： 10.2807/1560-7917.es2014.19.1.20666

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  37 in total

1.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

2.  Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants.

Authors:  Masatoki Sato; Masaki Ito; Shigeo Suzuki; Hiroko Sakuma; Aya Takeyama; Shinichi Oda; Masahiro Watanabe; Koichi Hashimoto; Kyohei Miyazaki; Yukihiko Kawasaki; Mitsuaki Hosoya
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

3.  Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan.

Authors:  Emi Takashita; Maki Kiso; Seiichiro Fujisaki; Masaru Yokoyama; Kazuya Nakamura; Masayuki Shirakura; Hironori Sato; Takato Odagiri; Yoshihiro Kawaoka; Masato Tashiro
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

4.  Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009-2017.

Authors:  Hebah A Al Khatib; Asmaa A Al Thani; Imed Gallouzi; Hadi M Yassine
Journal:  BMC Infect Dis       Date:  2019-04-11       Impact factor: 3.090

5.  Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.

Authors:  Lianlian Jiang; Giovanna Fantoni; Laura Couzens; Jin Gao; Ewan Plant; Zhiping Ye; Maryna C Eichelberger; Hongquan Wan
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

6.  Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference.

Authors:  Jennifer L McKimm-Breschkin; Shibo Jiang; David S Hui; John H Beigel; Elena A Govorkova; Nelson Lee
Journal:  Antiviral Res       Date:  2017-11-21       Impact factor: 5.970

7.  E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.

Authors:  Arnaud G L'Huillier; Yacine Abed; Tom J Petty; Samuel Cordey; Yves Thomas; Xavier Bouhy; Manuel Schibler; Audrey Simon; Yves Chalandon; Christian van Delden; Evgeny Zdobnov; Patricia Boquete-Suter; Guy Boivin; Laurent Kaiser
Journal:  J Infect Dis       Date:  2015-05-17       Impact factor: 5.226

8.  The arrival of highly pathogenic avian influenza viruses H5N8 in Iran through two windows, 2016.

Authors:  Minoo Motahhar; Hadi Keyvanfar; Abdolhamid Shoushtari; Mohammad Hossein Fallah Mehrabadi; Gholamreza Nikbakht Brujeni
Journal:  Virus Genes       Date:  2022-09-13       Impact factor: 2.198

9.  Oseltamivir-zanamivir combination therapy suppresses drug-resistant H1N1 influenza A viruses in the hollow fiber infection model (HFIM) system.

Authors:  Camilly P Pires de Mello; George L Drusano; Jonathan R Adams; Matthew Shudt; Robert Kulawy; Ashley N Brown
Journal:  Eur J Pharm Sci       Date:  2017-10-25       Impact factor: 4.384

10.  Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model.

Authors:  Leo Y Lee; Jie Zhou; Paulina Koszalka; Rebecca Frise; Rubaiyea Farrukee; Keiko Baba; Shahjahan Miah; Takao Shishido; Monica Galiano; Takashi Hashimoto; Shinya Omoto; Takeki Uehara; Edin J Mifsud; Neil Collinson; Klaus Kuhlbusch; Barry Clinch; Steffen Wildum; Wendy S Barclay; Aeron C Hurt
Journal:  PLoS Pathog       Date:  2021-05-06       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.